Dirk Müller-Wieland

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Insulin Resistance

Epidermal Growth Factor Receptor

Pulmonary Arterial Hypertension

Cardiovascular Disease

Top Venues

Diabetes, obesity & metabolism

European heart journal

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Nora Hennies, Sven W Görgens, Jonas Killer, Thorsten Otto, Lena M Richter, Dirk Müller-Wieland, Dennis Häckl
Prevalence of obesity and cardiovascular disease in adults with type 2 diabetes and use of diabetes medication in Germany: A claims data study. Diabetes, obesity & metabolism (2024)
Katharina Schütt, Massimo Federici, Marlo Verket, Nikolaus Marx, Dirk Müller-Wieland
The '10 commandments' for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. European heart journal (2024)
Katharina Schütt, Massimo Federici, Marlo Verket, Nikolaus Marx, Dirk Müller-Wieland
The '10 commandments' for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. European heart journal 45 (15) (2024)
Nikolaus Marx, Massimo Federici, Katharina Schütt, Dirk Müller-Wieland, Ramzi A Ajjan, Manuel J Antunes, Ruxandra M Christodorescu, Carolyn Crawford, Emanuele Di Angelantonio, Bjorn Eliasson, Christine Espinola-Klein, Laurent Fauchier, Martin Halle, William G Herrington, Alexandra Kautzky-Willer, Ekaterini Lambrinou, Maciej Lesiak, Maddalena Lettino, Darren K McGuire, Wilfried Mullens, Bianca Rocca, Naveed Sattar, null null
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. European heart journal (2023)
Julia Brandts, Sascha R Tittel, Peter Bramlage, Thomas Danne, Johanna M Brix, Stefan Zimny, Christoph H J Heyer, Reinhard W Holl, Dirk Müller-Wieland
Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in type 1 diabetes and type 2 diabetes: Lipid goal attainment in a large German-Austrian diabetes registry. Diabetes, obesity & metabolism (2023)
Malte Jacobsen, Pauline Rottmann, Till A Dembek, Anna L Gerke, Rahil Gholamipoor, Christopher Blum, Niels-Ulrik Hartmann, Marlo Verket, Jennifer Kaivers, Paul S Jäger, Ben-Niklas Baermann, Lutz Heinemann, Nikolaus Marx, Dirk Müller-Wieland, Markus Kollmann, Melchior Seyfarth, Guido Kobbe
Feasibility of Wearable-Based Remote Monitoring in Patients During Intensive Treatment for Aggressive Hematologic Malignancies. JCO clinical cancer informatics 6 (2022)
Thorsten Otto, Joanna Diesing, Julia Borchert, Elke Heitmann, Nanette C Schloot, Jeremie Lebrec, Dirk Müller-Wieland, Dennis Haeckl
Age-dependent prevalence of type 2 diabetes, cardiovascular risk profiles, and use of diabetes drugs in Germany using health claims data. Diabetes, obesity & metabolism (2022)
Martin Haluzík, Alice Cheng, Dirk Müller-Wieland, Jukka Westerbacka, Zsolt Bosnyak, Felipe Lauand, Lydie Melas-Melt, Janaka Karalliedde, Julio Rosenstock, Geremia B Bolli
Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial. Diabetes, obesity & metabolism 22 (8) (2020)
Dirk Müller-Wieland, Monika Kellerer, Katarzyna Cypryk, Dasa Skripova, Katja Rohwedder, Eva Johnsson, Ricardo Garcia-Sanchez, Raisa Kurlyandskaya, C David Sjöström, Stephan Jacob, Jochen Seufert, Nalina Dronamraju, Katalin Csomós
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes. Diabetes, obesity & metabolism 20 (11) (2018)
Tomas Jelenik, Ulrich Flögel, Elisa Álvarez-Hernández, Daniel Scheiber, Elric Zweck, Zhaoping Ding, Maik Rothe, Lucia Mastrototaro, Vivien Kohlhaas, Jörg Kotzka, Birgit Knebel, Dirk Müller-Wieland, Sarah Moellendorf, Axel Gödecke, Malte Kelm, Ralf Westenfeld, Michael Roden, Julia Szendroedi
Insulin Resistance and Vulnerability to Cardiac Ischemia. Diabetes 67 (12) (2018)